Skip to main content

Table 6 Comparison of Health-Related Quality of Life (HRQL) between known groups measured at baseline

From: Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study

 

% of participants reporting problems in each dimension

(n of participants with problems/n of participants without problems)

EQ-5D-Y

Utility Index

EQ-VASa

PROMIS PAISb raw Score

Mobility

Looking after myself

Doing usual activities

Having pain/discomfort

Feeling worried/sad/unhappy

Mean (SD)

n = 116

Mean (SD)

n = 119

Mean (SD)

n = 75

Asthma control—ACQc

 Well controlled

4.4%

(3/65)

1.5%

(1/67)

20.6%

(14/54)

14.7%

(10/58)

7.4%

(5/63)

.94 (.12)

88.2 (14.4)

10.9 (4.4)

 Intermediate

0.0%

(0/23)

4.3%

(1/22)

39.1%

(9/14)

21.7%

(5/18)

8.7%

(2/21)

.91 (.11)

78.6 (20.6)

11.3 (3.3)

 Not well controlled

13.0%

(3/20)

4.3%

(1/22)

45.8%

(11/13)

24.0%

(6/19)

8.0%

(2/23)

.89 (.12)

77.9 (18.5)

16.2 (6.2)

 P value

.12

.64

.04

.52

.98

.06

< .006

.002

 ESd

[95% CIe]

N/Af

N/Af

N/Af

N/Af

N/Af

− 0.38

[− 0.87 to 0.1]

0.66

[0.19 to 1.13]

1.11

[0.45 to 1.76]

Asthmatic exacerbations (last 6 months)

 No

6.3%

(4/60)

1.5%

(1/64)

23.1%

(15/50)

13.6%

(9/57)

6.1%

(4/62)

0.94 (0.11)

84.6 (18.3)

11.3 (4.8)

 Yes

3.8%

(2/51)

3.8%

(2/50)

35.8%

(19/34)

22.6%

(12/41)

9.4%

(5/48)

0.91 (0.12)

84.0 (15.6)

12.9 (5.0)

 P value

.55

.43

.13

.20

.49

.12

.46

.15

 ES

[95% CI]

N/Af

N/Af

N/Af

N/Af

N/Af

− 0.24

[− 0.61 to 0.13]

0.03

[− 0.33 to 0.4]

0.35

[− 0.13 to 0.82]

Frequency of SABAg use reported by patients (last 4 weeks)

 Less than once per week

4.3%

(3/66)

1.4%

(1/69)

18.6%

(13/57)

11.3%

(8/63)

5.6%

(4/67)

0.95 (0.09)

88.4 (14.2)

11.4 (4.9)

 Once or more per week

6.7%

(3/42)

4.5%

(2/42)

46.7%

(21/24)

28.9%

(13/32)

11.1%

(5/40)

0.88 (0.14)

77.2 (19.4)

12.7 (5.0)

 P value

.59

.31

.001

.02

.28

.004

.001

.27

 ES

 [95% CI]

N/Af

N/Af

N/Af

N/Af

N/Af

− 0.59

[− 0.98 to − 0.2]

0.68

[0.30 to 1.07]

0.26

[− 0.21 to 0.73]

Second-hand smoke exposure

 Not exposed

5.1%

(4/75)

1.3%

(1/79)

27.5%

(22/58)

17.3%

(14/67)

9.9%

(8/73)

0.92 (0.11)

85.6 (15.4)

11.6 (4.7)

 Exposed

12.5%

(2/14)

13.3%

(2/13)

43.8%

(7/9)

37.5%

(6/10)

6.3%

(1/15)

0.87 (0.16)

73.5 (19.7)

13.7 (6.6)

 P value

.27

.01

.20

.07

.65

.35

.02

.21

 ES

 [95% CI]

N/Af

N/Af

N/Af

N/Af

N/Af

− 0.45

[− 1.01 to 0.1]

0.75

[0.21 to 1.30]

0.42

[− 0.23 to 1.07]

  1. aEQ-VAS: EuroQol-Visual Analogue Scale
  2. bPROMIS-PAIS: Patient-Reported Outcomes Measurement Information System-Pediatric Asthma Impact Scale
  3. cACQ: Asthma Control Questionnaire
  4. dES: effect size
  5. eCI: interval confidence
  6. fN/A: not applicable
  7. gSABA: Short-Acting β-Agonists